Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000492

Type of data
NGS (RNA-seq, ChIP-seq)
Access criteria
Controlled-access (Type I)
Total data volume
208 GB
File formats
  • FASTQ
Research
hum0201
Date published
2021-11-30
Date modified
2022-10-27
DDBJ Search
JGAD000492 (opens in a new tab)
JGA Study
JGAS000378 (opens in a new tab)

Analysis method

RNA-seq

Materials and participants
Neoplastic disease: 23 + 4 cases (35+ 5 samples)
Small cell lung cancer (ICD10: C34)
Biliary tract cancer (ICD10: C23, C24, C78)
Colon cancer (ICD10: C18-20)
Duodenal cancer (ICD10: C17)
Esophageal cancer (ICD10: C15)
Stomach cancer (ICD10: C16, C78)
Liver cancer (ICD10: C22)
Pancreatic cancer (ICD10: C25)
  • Health status
    Mixed
  • Subject count
    40 (Sample)
Disease
Small cell lung cancer (C34)
Biliary tract cancer (C23, C24, C78)
Colon cancer (C18, C19, C20)
Duodenal cancer (C17)
Esophageal cancer (C15)
Stomach cancer (C16, C78)
Liver cancer (C22)
Pancreatic cancer (C25)
Sample description
RNAs extracted from organoids established from tumor tissues and a normal epithelial tissue of the patients
RNAs extracted from organoids with BET bromodomain inhibitor established from tumor tissues and a normal epithelial tissue of colon cancer patients
  • Tissue
    Colon, Organoid
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
TruSeq RNA Library Prep Kit
TruSeq Stranded mRNA Library Prep Kit
Fragmentation
Heat treatment
Platform
Illumina HiSeq 2500
Illumina HiSeq X
Illumina NovaSeq 6000
Read type
Paired-end
Read length
250 bp
150 bp
Data use policy
NBDC data sharing policy (JGAP000001)

ChIP-seq

Materials and participants
Neoplastic disease: 4 cases (5 samples)
Colon cancer (ICD10: C18)
  • Health status
    Mixed
  • Subject count
    5 (Sample)
Disease
Colon cancer (C18)
Sample description
DNAs extracted from organoids derived from colon cancer tissues and a normal epithelial tissue of the patients, and immunoprecipitated with an anti-histone antibody (H3K27Ac)
  • Tissue
    Colon, Organoid
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
ChIP-seq
Target
N/A
Reagent kit
Illumina Tagment DNA TDE1 Enzyme and Buffer Kits
Fragmentation
Ultrasonic fragmentation (Bioruptor Ⅱ)
Platform
Illumina HiSeq X
Read type
Paired-end
Read length
150 bp
Data use policy
NBDC data sharing policy (JGAP000001)